查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1588576

全球流体管理监控系统市场 - 2024-2031

Global Fluid Management Monitoring System Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 202 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球流体管理监控市场在2023年达到19.6亿美元，预计到2031年将达到34.3亿美元，在2024-2031年预测期间复合年增长率为6.5%。

液体管理过程是医学中最复杂的领域之一，尤其是在强调每位患者个人需求的住院环境中。在许多情况下，尤其是卧床不起的患者，水合控制的可靠性受到损害，导致高发病率甚至死亡率。因此，液体管理非常重要，因为它可以满足生理需求，包括流失的液体。

市场动态：

驱动程式和限制

慢性病盛行率上升

由于肾臟病、心臟衰竭、糖尿病等慢性疾病病例的不断增加，流体管理监测系统的全球市场正在大幅成长。此类疾病需要仔细、准确的监测，以避免併发症并确保积极的结果。透过此类投资，医疗保健提供者正在购买能够即时提供准确资料的高阶系统，以实现及时、更好的最终结果。

随着人口老化和生活方式趋势的不断增长，慢性病在全球舞台上的盛行率不断增加，对可靠的液体管理控制解决方案的需求预计将会增加，使这些系统能够支持处理大多数患者的护理复杂性。

例如，根据 Mayo Clinic 2023 的数据，由于公共卫生状况的改善，传染病和非传染性疾病之间的转变始于 1900 年代初。随着个人寿命的延长，慢性病盛行率和费用持续上升，预计到 2030 年费用将达到 47 兆美元。

流体管理监控系统成本高昂

全球流体管理监测系统市场也未能倖免于激烈的竞争，这主要是由于成本高昂，特别是在医院面临资源和预算限制的发展中地区。这种财务限制阻碍了这些先进设备的大规模实施，即使需要它们来有效管理有液体问题的患者。此外，在资源匮乏的环境中，维护、训练和软体升级等成本也限制了该技术的使用。

例如，HysteroLux 流体管理系统控制单元的成本约为 4000-10,000 美元，与其他公司的产品成本一样高，这阻碍了整个市场在预测期内的成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 慢性病盛行率上升
    • 限制
      • 流体管理监控系统成本高昂
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 报销分析
  • 专利分析
  • SWOT分析
  • DMI 意见

第 6 章：依产品类型

  • 流体管理软体
  • 流体管理设备

第 7 章：按申请

  • 手术程序
  • 心血管外科
  • 骨科手术
  • 神经外科
  • 一般外科
  • 泌尿科
  • 重症监护
  • 儿科护理
  • 新生儿护理
  • 伤口处理

第 8 章：最终用户

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 家庭医疗保健提供者

第 9 章：按配销通路

  • 直销
  • 医疗用品经销商
  • 网上销售

第 10 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Baxter International Inc.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Fresenius Medical Care AG & Co. KGaA
  • Cardinal Health, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Medtronic plc
  • Olympus Corporation
  • Smith's Medical
  • Ecolab Inc.
  • KARL STORZ GmbH & Co. KG

第 13 章：附录

简介目录
Product Code: MD8720

Overview

The global fluid management monitoring system market reached US$ 1.96 billion in 2023 and is expected to reach US$ 3.43 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031.

The process of fluid management is one of the most complicated areas in medicine, especially in an inpatient setting that emphasizes the individual needs of each patient. In many instances, especially in patients that are confined to bed, the reliability of the control of hydration is impaired, with resultant high morbidity and even mortality. Fluid management, therefore, is very important because it satisfies the physiological needs, including fluids that are lost.

Market Dynamics: Drivers & Restraints

Rise in the Prevalence of Chronic Diseases

The worldwide marketplace for fluid management monitoring systems is seeing tremendous growth owing to the rising cases of chronic diseases, such as kidney disease, heart failure, diabetes, and others. Such diseases require careful and exact monitoring in order to avoid complications and ensure positive results. With such investments, healthcare providers are purchasing high-end systems that provide accurate data in real-time for timely and better end results.

As the prevalence of chronic diseases increases on the global stage with the growing aging population and lifestyle trends, the need for dependable solutions for fluid management control is projected to increase hence making these systems supportive in dealing with the care complexity of most patients.

For instance, according to Mayo Clinic 2023, the transition between infectious and noncommunicable diseases began in the early 1900s due to improved public health. As individuals live longer, chronic disease prevalence and cost continue to rise, with the estimated cost reaching $47 trillion by 2030. Individual lifestyle, behaviors, and community factors significantly influence the development and management of chronic diseases.

High costs of Fluid Management Monitoring System systems

The global fluid management monitoring systems market is not spared from the stiff competition, mostly due to the high costs involved especially in developing regions where hospitals deal with resource and budget constraints. This financial limit prevents a large-scale implementation of these advanced equipment, even when they are needed for effective management of patients with fluid problems. Also, in low resource environments, the cost of maintenance, training, and software upgrades, etc. limits the access of this technology.

For instance, HysteroLux Fluid Management System Control Unit costs around U$ 4000-10,000 like this other company products cost varies high which hinders the overall market to grow during the forecast period.

Segment Analysis

The global fluid management monitoring system market is segmented based on product type, , application, end user, distribution channel and region.

Fluid management devices segment is expected to dominate the market share

The fluid management devices segment are expected to hold a significant portion of the market share. In healthcare environments such as the operating theatre, the emergency department, and the intensive care unit, fluid management devices play an important role in controlling and measuring patient's fluid saturation levels. They allow for the monitoring of the data in real-time thereby minimizing the chances of over hydration or dehydration of a patient.

The development of technology incorporated solid state devices to allow collection, analysis of data, and easy interaction with EHR'S (Electronic Health Records) enhancing clarity of medical decisions and increasing the recovery chances in patients. Rising occurrences of chronic illnesses, geriatric populace, and less invasive surgical procedures are stimulating the uptake of these devices, making them essential devices in the system for fluid management monitoring market.

For instance, in August 2024, Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitect, a flexible, single-use solution for biopharmaceutical fluid management. The platform builds on previous products like puresu and asepticsu, aiming to streamline processes, protect products, and reduce regulatory burden.

Geographical Analysis

North America is expected to hold a significant position in the fluid management monitoring system market share

North America is expected to hold a significant position in the global Fluid Management Monitoring System market during the forecast period due to the rapid growth in the geriatric population, the rise in chronic diseases, FDA clearance, the increase in research and development, an increase in technology and many more. Higher living standards and the rise in the number of people suffering from cancer has brought about an increase in demand for fluid administration systems, disposable accessories and also for minimally invasive surgeries.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

Moreover, in August 2022, Zynex, a medical technology company, has started enrolling in an ongoing apheresis clinical trial using its second-generation fluid monitoring system, the CM-1600. The study uses the CM-1500 and CM-1600 devices during an apheresis procedure to refine the system's patented Relative Index.

Market Segmentation

By Product Type

  • Fluid Management Software
  • Fluid Management Devices

By Application

  • Surgical Procedures
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • General Surgery
  • Urology Surgery
  • Critical Care
  • Pediatric Care
  • Neonatal Care
  • Wound Management

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Home Healthcare Providers

By Distribution Channel

  • Direct Sales
  • Medical Supply Distributors
  • Online Sales

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cardinal Health, Inc., Stryker Corporation,B. Braun Melsungen AG, Medtronic plc, Olympus Corporation, Smiths Medical, Ecolab Inc, KARL STORZ GmbH & Co. KG among others.

Key Developments

  • In July 2024, Boston Scientific Corporation is considering the sale of its fluid management business, formerly North American Medical Instruments Corp., as part of its ongoing asset review. The business, which produces products for managing fluid and measuring pressure during angiography and angioplasty procedures, is expected to include the company's facilities in Glens Falls, New York and Tullamore, Ireland.

Why Purchase the Report?

  • To visualize the global fluid management monitoring system market segmentation based on product type, application, end user, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of fluid management monitoring system market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global fluid management monitoring system market report would provide approximately 70 tables, 69 figures, and 202 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs of Fluid Management Monitoring System Systems
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Fluid Management Software*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Fluid Management Devices

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Surgical Procedures*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiovascular Surgery
  • 7.4. Orthopedic Surgery
  • 7.5. Neurosurgery
  • 7.6. General Surgery
  • 7.7. Urology Surgery
  • 7.8. Critical Care
  • 7.9. Pediatric Care
  • 7.10. Neonatal Care
  • 7.11. Wound Management

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics
  • 8.5. Home Healthcare Providers

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Direct Sales*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Medical Supply Distributors
  • 9.4. Online Sales

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
      • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.3.1. The U.S.
      • 10.2.3.2. Canada
      • 10.2.3.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
      • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.3.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.3.1. Germany
      • 10.3.3.2. UK
      • 10.3.3.3. France
      • 10.3.3.4. Italy
      • 10.3.3.5. Spain
      • 10.3.3.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
      • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.4.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.3.1. Brazil
      • 10.4.3.2. Argentina
      • 10.4.3.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
      • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.5.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.3.1. China
      • 10.5.3.2. India
      • 10.5.3.3. Japan
      • 10.5.3.4. South Korea
      • 10.5.3.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
      • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
      • 10.6.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Baxter International Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Fresenius Medical Care AG & Co. KGaA
  • 12.3. Cardinal Health, Inc.
  • 12.4. Stryker Corporation
  • 12.5. B. Braun Melsungen AG
  • 12.6. Medtronic plc
  • 12.7. Olympus Corporation
  • 12.8. Smith's Medical
  • 12.9. Ecolab Inc.
  • 12.10. KARL STORZ GmbH & Co. KG

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us